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S U M M A R Y
Surgical site infections (SSI) are postoperative complications that constitute a major public health
problem. We present a rare case report of infection by Buttiauxella agrestis, a member of the
Enterobacteriaceae family, occurring after a cesarean delivery in a young woman with no comorbidities.
The authors further discuss the origin of this infection.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Surgical site infections (SSI) are postoperative complications
that constitute a major public health problem. The Centers for
Disease Control and Prevention (CDC) report that SSIs represent
the most common healthcare-associated infection in the USA, with
an overall SSI rate of 1.9% and an associated mortality rate of 3%.1
From an obstetrics viewpoint, wound infection is diagnosed in 6%
to 27% of patients, generally four to seven days after cesarean.2 The
most commonly reported pathogens in post-cesarean SSIs are
Staphylococcus aureus (anaerobic), Enterobacteriaceae and Strep-
tococcus.1 We present the ﬁrst known report of a Buttiauxella
agrestis infection occurring after cesarean delivery in a young
woman with no comorbidity.
2. Case report
We present the interesting case of a 17-year-old primigravida at
40 weeks of gestation who presented to the hospital maternity unit
in July 2013. Antibiotic prophylaxis (2 g cefazolin) was administered* Corresponding author. Tel.: +55 51 33145239; fax: +55 51 33421330.
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without complications. The patient was discharged 3 days after
admission and given standard recommendations as to postoperative
precautions and care.
The patient was readmitted to hospital 6 days later complaining
of fever and reporting an oozing discharge from the incision site for
the previous 2 days. On physical examination, a deep surgical site
infection (SSI) was diagnosed with drainage of purulent secretions.
A sample was collected and referred to the department of
microbiology for detailed analysis. Direct microscopy examination
was carried out and revealed the presence of leukocytes and Gram-
negative organisms. The vials were processed using an automated
culture system (bioMe´rieux). A surgical drainage approach was
adopted plus intravenous administration of a two-drug combina-
tion of clindamycin plus gentamicin for 5 days in accordance with
the hospital protocol. At the end of the 5-day period, the patient
was asymptomatic and afebrile, with complete clinical improve-
ment. The patient was discharged from hospital with oral
clindamycin plus cefuroxime for a further 9-day period.
Subsequent to patient discharge, test results conducted by the
department of microbiology using a Vitek 2 automated system for
bacterial identiﬁcation and antibiotic susceptibility, identiﬁed the
growth of Buttiauxella agrestis in the purulent material taken from
the SSI. This was further identiﬁed and conﬁrmed using the Vitek
MS v2.0 matrix-assisted laser desorption ionization time-of-ﬂightciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
V.S. Antonello et al. / International Journal of Infectious Diseases 22 (2014) 65–6666(MALDITOF) mass spectrometry system. Minimum inhibitory
concentration (MIC) testing conﬁrmed the bacteria to be suscepti-
ble to all antibiotics tested, including gentamicin, ciproﬂoxacin,
amoxicillin–clavulanic acid, ampicillin, cefoxitin, ceftriaxone,
piperacillin–tazobactam, and ertapenem.
A patient interview was conducted to ascertain the possible
source of infection and to understand the epidemiology of B.
agrestis infection at the post-cesarean surgical site. The patient is
employed as a supermarket cashier and lives in the city of Viama˜o,
in the southern-most state of Brazil. Although an urban area,
Viama˜o is also close to regions of woodland and is subject to
extreme damp. The house where the patient lives is of masonry
construction and has adequate sanitation. Lastly, the patient
described her care of the wound site as having used soap and water
only and she denied using well water in her daily life. Written
informed consent from the patient was obtained for the publica-
tion of this case report.
3. Discussion
Buttiauxella agrestis, a member of the Enterobacteriaceae family,
is a small Gram-negative rod-shaped facultative anaerobic
organism found in a variety of places in nature: soil, water, ﬁsh,
cockroaches, and mollusks, including slugs and snails.3 Only a few
cases with clinical relevance involving B. agrestis have been
described in the medical literature to date – appendicitis and
wound infection – although it is difﬁcult to distinguish between an
etiological agent and colonizer of a pre-existing disease focus.4
Limited susceptibility studies have been performed on B.
agrestis. The results for strains tested by broth microdilution have
indicated that the isolates were resistant to ampicillin, amoxicil-
lin–clavulanic acid, ticarcillin, cephalothin, cefoxitin, cefotaxime,
doxycycline, trimethoprim, and chloramphenicol, based upon
MIC90 values. However, MIC50 has indicated that many isolates are
susceptible to gentamicin, amikacin, and colistin.5 Another report
regarding the Buttiauxella species (including one case of B. agrestis)
showed susceptibility to ampicillin, sulbactam, tazobactam, and
cephalosporins of all generations.6 The current isolate of B. agrestis
showed susceptibility to all antibiotics tested, including gentami-
cin, ciproﬂoxacin, amoxicillin–clavulanic acid, ampicillin, cefox-
itin, ceftriaxone, piperacillin–tazobactam, and ertapenem. The
successful patient recovery was probably due to the combinationof prompt surgical drainage of the SSI and correct empiric
administration of intravenous gentamicin for 5 days, with
subsequent oral prescription of cefuroxime for a further 9 days.
The present report is an unusual case in the literature of a B.
agrestis infection occurring at a post-cesarean surgical site. The
ﬁrst and most probable explanation of the origin of this infection is
that the patient became infected with B. agrestis during her stay at
home. This is likely due to the proximity to the woodland and the
local humidity, given that the causative bacterium is found in
water, soil, and earthworks.2 The second and more remote
possibility is that the infection was hospital acquired, however
the healthcare setting does not provide the usual habitat for B.
agrestis and there have been no previous reports of the isolation of
B. agrestis in a hospital environment.
In summary, the authors believe this report contributes to the
understanding of infections caused by germs previously consid-
ered to be non-pathogenic in humans and to indicate an
appropriate choice of antimicrobial treatment.
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